White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That’s Set To Take Effect Later This Year
Connecticut Governor Signs Bill To Expand Psychedelics Pilot Program In Preparation For Federal FDA Approval
Congressional Committee Directs Feds To Keep Testing Truck Drivers For Marijuana, Regardless Of Trump’s Rescheduling Move
Louisiana Will Let Terminally Ill Patients Use Medical Marijuana In Hospitals After Governor Allows Bill To Take Effect Without His Signature
Alabama Medical Marijuana Sales Finally Launch, Years After Lawmakers Passed Legalization
2 In 3 Americans Who Use Marijuana Say It Helps Them Sleep Better, New Survey Shows
Hemp-Based Plastic Shows Promise As Environmentally Friendly Alternative To Traditional Packaging Materials, Study Finds
Marijuana Components Have ‘Consistent’ Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows
Another Study Debunks Lazy Stoner Stereotype, Linking Marijuana Use To An Increase In Some Kinds Of Exercise
VA Launches New Study On MDMA To Treat Veterans With PTSD And Alcohol Use Disorder
WNBA Removes Marijuana From Banned Substances List And Sets Rules For Player Endorsements Of Hemp CBD Products
Americans Say Marijuana Is Less Cool Than Math And Country Music—But Is Cooler Than Guns Or Cryptocurrency, Survey Shows
Politicians And Major Brands Celebrate Cannabis Culture On 4/20
Woody Harrelson And Bill Maher Complain That Marijuana Taxes Are Too High While Smoking Joints At The Dispensary They Own Together
WNBA Offers To End Marijuana Testing For Women’s Basketball Players As Part Of Reported Deal With Union
Federal Labor Decision Inspires More Missouri Marijuana Workers To Seek Unionization
Missouri Marijuana Workers Win Union Vote After Federal Officials Reject Company’s Argument On Blocking Ballots
Target Is Launching Hemp THC Drink Sales In Three Of The U.S.’s Most Populous States
Target Expands Involvement In Hemp THC Drinks Market With 72 New Licenses In Minnesota
Marijuana Sales Are Rising And Alcohol Is On The Decline As Consumer Preferences Evolve, Government Data In Canada Shows
WNBA takes cannabis off banned list & sets player endorsement rules (Newsletter: June 5, 2026)
Wisconsin governor candidates pledge cannabis action if elected (Newsletter: June 4, 2026)
Amendments to save hemp THC from ban are blocked in Congress (Newsletter: June 3, 2026)
Trump sued over cannabis rescheduling (Newsletter: June 2, 2026)
GOP lawmakers push to save hemp from impending federal ban (Newsletter: June 1, 2026)
Published
on
By
Advocacy organizations on both sides of the marijuana legalization debate have filed notices of intent to participate in a hearing on broad federal rescheduling of cannabis that the Drug Enforcement Administration (DEA) is set to begin next month.
Acting Attorney General Todd Blanche last month issued an order that immediately reclassified state-licensed medical cannabis, as well as marijuana products approved by the Food and Drug Administration (FDA) from Schedule I of the Controlled Substances Act (CSA) to Schedule III.
Under a separate order the acting attorning general signed, DEA will hold a hearing on the issue of more comprehensively moving marijuana to Schedule III, starting on June 29.
The National Organization for the Reform of Marijuana Laws (NORML) announced on Tuesday that it has filed notice of intention to participate in the proceedings.
“Marijuana cannot lawfully remain in Schedule I,” Joseph A. Bondy, chair of NORML’s Board of Directors and counsel to the group, said in a press release. “But Schedule III is not the end of the road. It is, at most, an interim correction. It does not resolve the federal government’s continued failure to recognize adult cannabis consumers who are acting lawfully under state law.”
The group argued in its filing that the hearing record will be incomplete without included the perspective of adult marijuana consumers that the group represents.
NORML doesn’t oppose moving cannabis to Schedule III, under which cannabis would remain a medicalized substance, but it argues that a more appropriate reform would be to remove cannabis from the CSA altogether—a process called descheduling.
“Adult cannabis consumers do not become patients because federal law lacks a better category for them,” Bondy said. “They are not abusing medicine. They are participating in state-regulated adult-use systems enacted by voters and legislatures.”
⚖️ "Consumers deserve representation in any hearing involving the future legal status of marijuana."
NORML is telling the DEA that cannabis consumers cannot be excluded from one of the biggest federal marijuana policy debates in decades.
🔗 Read more: https://t.co/5vbqatSGxX pic.twitter.com/2Xm2qlR7W9
— NORML (@NORML) May 26, 2026
“NORML is not appearing as an industry-tax-relief organization, and it is not appearing as a medical-only advocacy group,” he said. “NORML is appearing because cannabis consumers are directly affected by federal scheduling, and no other likely participant represents them as consumers.”
Meanwhile, the prohibitionist organization Smart Approaches to Marijuana also wants to participate in next month’s DEA hearing and has filed intent to do so.
“This fight is not over, and we will not sit on the sidelines while the federal government hands Big Marijuana its biggest political win in history,” Kevin A. Sabet, the group’s president and CEO said. “Rescheduling marijuana to Schedule III has no scientific basis and would hand the industry billions of dollars in rewards for targeting children.”
SAM Files notice of intent to participate in the DEA rescheduling hearing. pic.twitter.com/YpXJjsIcQ8
— Smart Approaches to Marijuana (@learnaboutsam) May 26, 2026
Notices of intent to participate in the hearing, which is set to conclude no later than July 15 under Blanche’s order, need to be filed by Thursday in order to be considered. Such requests are required to:
“The purpose of the hearing is to ‘receiv[e] factual evidence and expert opinion regarding’ whether marijuana should be transferred to schedule III of the list of controlled substances,” Blanche’s notice said.
The acting attorney general will select witnesses who will be invited to participate, as well as an administrative law judge (ALJ) to oversee the proceedings.
“The ALJ’s authorities include the power to hold conferences to simplify or determine the issues in the hearing or to consider other matters that may aid in the expeditious disposition of the hearing; require parties to state their position in writing; sign and issue subpoenas to compel the production of documents and materials to the extent necessary to conduct the hearing; examine witnesses and direct witnesses to testify; receive, rule on, exclude, or limit evidence; rule on procedural items; and take any action permitted by the presiding officer under DEA’s hearing procedures and the” Administrative Procedures Act, Blanche wrote.
A prior hearing process on the marijuana rescheduling process that was initiated by the Biden administration stalled last year amid litigation over alleged improper communications and witness selection.
Meanwhile, the already-enacted rescheduling of state-licensed medical cannabis is already having broad impacts.
The Congressional Research Service published a report on the current cannabis rescheduling move explaining that certified patients who possess medical marijuana from state-licensed dispensaries now have certain protections under Schedule III. “The order appears to authorize end users to possess marijuana for medical use without a CSA-compliant prescription,” it says.
The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has posted a draft update to a gun purchase form to acknowledge the federally legal status of medical marijuana under rescheduling. The revised section in question notably says that only “use or possession of marijuana for recreational purposes” is federally prohibited, leaving out the prior form’s mention of medical cannabis.
The U.S. Department of the Treasury and Internal Revenue Service (IRS) said they plan to issue new tax guidance for the marijuana industry following rescheduling. The reform will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions they’re currently barred from under an IRS code known as 280E that doesn’t apply to Schedule III substances.
Even DEA, which has long opposed cannabis legalization and was accused of stalling the rescheduling process initiative by the Biden administration, has launched a registration process for state-legal marijuana businesses to take advantage of federal benefits that come with the reform.
The Department of Transportation, on the other hand, issued guidance saying that use of state-legal medical cannabis is still no excuse for a positive drug test by truck drivers, pilots and other safety-sensitive workers.
Tom Angell is the editor of Marijuana Moment. A 25-year veteran in the cannabis and drug law reform movement, he covers the policy, politics, science and culture of marijuana, psychedelics and other substances. He previously reported for Forbes, Marijuana.com and MassRoots, and was given the Hunter S. Thompson Media Award by NORML and has been named Journalist of the Year by Americans for Safe Access. As an activist, Tom founded the nonprofit Marijuana Majority and handled media relations, campaigns and lobbying for Law Enforcement Against Prohibition and Students for Sensible Drug Policy.
Add Marijuana Moment as a preferred source on Google.
All the cannabis news you need, all in one place. Copyright © 2017-2026 Marijuana Moment LLC ® and Tom Angell